Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Mayank Mohan Agarwal is active.

Publication


Featured researches published by Mayank Mohan Agarwal.


BJUI | 2011

Safety and efficacy of ultrasonography as an adjunct to fluoroscopy for renal access in percutaneous nephrolithotomy (PCNL)

Mayank Mohan Agarwal; Madhu S. Agrawal; Abhinav Jaiswal; Deepak Kumar; Himanshu Yadav; Prashant Lavania

Study Type – Therapy (case series)


Urology | 2008

Tamsulosin Facilitates Earlier Clearance of Stone Fragments and Reduces Pain After Shockwave Lithotripsy for Renal Calculi : Results From an Open-Label Randomized Study

Vineet Naja; Mayank Mohan Agarwal; Arup K. Mandal; Shrawan Kumar Singh; Ravimohan Mavuduru; Santosh Kumar; Naveen Acharya; Nitin Gupta

OBJECTIVES To evaluate the role of tamsulosin in the clearance of fragments after extracorporeal shock wave lithotripsy (ESWL) to treat renal calculi. METHODS In this open-label prospective randomized study conducted at our institute from 2006 to 2007, 139 patients with normal renal function and a single radiopaque renal calculus, 5-20 mm, undergoing ESWL were enrolled. All patients underwent ESWL every 3 weeks until success or for <or=3 months, whichever was earlier. They were randomly assigned to 2 groups with respect to whether they had received tamsulosin, 0.4 mg/d. The primary endpoint was the success rate, and the secondary endpoints were clearance time, sessions required for clearance, pain intensity, incidence of steinstrasse, and the need for auxiliary procedures. RESULTS Of the 139 patients, 51 in group 1 and 65 in group 2 completed the requisite follow-up. The demographic profile of both groups was comparable. The success rate after 1, 2, and 3 ESWL sessions was greater in group 1 than in group 2 (52.9%, 78.4%, and 94.1% vs 30.8%, 52.3%, and 75.4%; P = .016, P = .004, and P = .007, respectively). The total days required for success (35.53 +/- 19.47 vs 47.22 +/- 23.64; P = .006), total ESWL sessions required for success (1.66 vs 2.16; P = .005), and the pain experienced (visual analog scale score 28.67 +/- 20.35 vs 47.30 +/- 24.98, respectively; P = .0001) were significantly less in group 1. Two patients in group 1 and 9 in group 2 developed steinstrasse (P = .10); conservative management was successful in 1 patient in each group (P = .345). Three patients in group 1 and 10 in group 2 required auxiliary procedures (P = .14). CONCLUSIONS The results of our study have shown that tamsulosin facilitates earlier clearance of fragments after ESWL to renal calculi and helps reduce the severity of the pain. It tended to facilitate spontaneous clearance of steinstrasse; however, this requires additional evaluation.


Urology | 2011

Urodynamic Profile of Diabetic Patients With Lower Urinary Tract Symptoms: Association of Diabetic Cystopathy With Autonomic and Peripheral Neuropathy

Rahul Bansal; Mayank Mohan Agarwal; Manish Modi; Arup K. Mandal; Shrawan Kumar Singh

OBJECTIVES To evaluate the association between diabetic cystopathy (DC) and neuropathy (autonomic and peripheral) in patients with diabetes mellitus (DM) presenting with lower urinary tract symptoms (LUTS). METHODS Men with DM who presented with bothersome LUTS were enrolled from January 2008 to June 2009. Their demographic and clinical profiles were noted. Multichannel urodynamic studies were performed using the Solar Silver digital urodynamic apparatus. Hand and foot sympathetic skin responses, and motor and sensory nerve-conduction velocity studies were performed using the Meditronic electromyographic/evoked potentials system. RESULTS A total of 52 men (mean age 61.3 ± 12.1 years, DM duration 11.0 ± 7.5 years) completed the study protocol. Of these 52 men, abnormal sympathetic skin responses, motor and sensory nerve-conduction velocity studies, and combined neuropathy (all 3 tests abnormal) were noted in 80.7% 57.7%, 57.7%, and 51.9%, respectively. Urodynamic studies showed impaired first sensation (>250 mL), increased capacity (>600 mL), detrusor underactivity, detrusor overactivity, high postvoid residual urine volume (more than one third of capacity), and bladder outlet obstruction (Abrams-Griffiths number >40) in 23.1%, 25.0%, 78.8%, 38.5%, 65.4%, and 28.8% of the men, respectively. Both sensory and motor DC correlated with abnormal motor and sensory nerve-conduction velocity studies (P = .015 and P = .005, respectively). Only motor DC correlated with abnormal sympathetic skin responses (P = .015). The correlations were stronger in the presence of combined neuropathy (sensory DC, P = .005; motor DC, P = .0001). CONCLUSIONS Men with DM and LUTS can present with varied urodynamic findings, apart from the classic sensory or motor cystopathy. A large proportion of these patients will have electrophysiologic evidence of neuropathy, and electrophysiologic evidence of neuropathy can moderately predict the presence of cystopathy.


Urologia Internationalis | 2009

Comparison of HoLEP and TURP in Terms of Efficacy in the Early Postoperative Period and Perioperative Morbidity

R.M. Mavuduru; A. Mandal; S. K. Singh; Naveenchandra Acharya; Mayank Mohan Agarwal; S. Garg; Santosh Kumar

Objectives: We conducted this study to compare the safety and efficacy of transurethral resection of the prostate (TURP) and holmium laser prostatectomy. Methods: A total of 30 patients eligible for surgery for symptomatic benign prostatic hyperplasia were included in the study. They were randomized into two groups of 15 each. The patients were evaluated at 3 weeks, 3 and 9 months. Results: Preoperative parameters were comparable between the 2 groups. The mean operative time was longer in the holmium laser enucleation of prostate (HoLEP) group (53 ± 9.84 vs. 43 ± 9.36 min; p = 0.001). The intraoperative adverse events were comparable. The mean traction time (26.80 ± 5.9 vs. 19.60 ± 3.6 h; p = 0.0001), irrigation time (30 ± 7.68 vs. 19.40 ± 1.15 h; p = 0.0001), and duration of indwelling catheter (78.20 ± 17.84 vs. 46.42 ± 14.25 h; p = 0.0001) were significantly less in the HoLEP group as compared to the TURP group. Two patients (13.66%) in the TURP group had significant hematuria. Two patients in the HoLEP group vs. none in the TURP group developed urinary incontinence (p < 0.05). Significant improvements were observed in IPSS score, PFRs and PVRs in both the groups and maintained at 9 months. Conclusions: HoLEP is safe and effective in the surgical management of benign prostatic hyperplasia, with the advantage of reduced intraoperative hemorrhage and perioperative morbidity.


Urology | 2009

Is There an Adjunctive Role of Tamsulosin to Extracorporeal Shockwave Lithotripsy for Upper Ureteric Stones: Results of an Open Label Randomized Nonplacebo Controlled Study

Mayank Mohan Agarwal; Vineet Naja; Shrawan Kumar Singh; Ravimohan Mavuduru; Uttam Mete; Santosh Kumar; Arup K. Mandal

OBJECTIVES To investigate the role of tamsulosin as an adjunct to management of upper ureteric stones (UUS) with extracorporeal shock wave lithotripsy (SWL). METHODS In this prospective, randomized, open label study, patients with single UUS (for SWL) were randomly assigned into 2 groups based on whether they received 0.4 mg tamsulosin (group A and B, respectively) during treatment. Repeat SWL was performed at week 1, 3, and 5 after first session. Primary outcome variables were success rate and pain intensity. RESULTS A total of 40 patients (20 each group) completed the requisite follow-up. Success rate was higher in group A after 1 SWL-session (55% vs 25%, respectively; P = .05). There was an insignificant trend of decreased number of days (30.7 +/- 19.7 vs 39.0 +/- 19.9; P = .19), number of SWL sessions (1.6 vs 2.0; P = .10), and pain experienced (score on visual analog scale, 25.3 +/- 17.9 vs 38.3 +/- 28.0, respectively; P = .41) in group A. Three in group A and 6 in B developed steinstrasse (P = .69). Overall, 1 in group A required auxiliary procedures as compared with 3 in control group (P = .60). CONCLUSIONS Tamsulosin improves clearance rate of UUS after single SWL. However, it does not provide significant advantage in terms of decreasing pain associated with this treatment.


Cancer | 2005

Factors affecting bone mineral density in patients with prostate carcinoma before and after orchidectomy

Mayank Mohan Agarwal; Niranjan Khandelwal; Arup K. Mandal; Satyawati V. Rana; Vivek Gupta; Vaddi Chandra Mohan; Gottapu V. M. K. Kishore

Orchidectomy is an accepted form of androgen‐deprivation therapy (ADT) for prostate carcinoma. Osteoporosis is common in elderly individuals and is accelerated by ADT. The authors studied changes in bone mineral density (BMD) after ADT and factors that affected those changes.


BJUI | 2011

Medical therapy for calculus disease

Shrawan Kumar Singh; Mayank Mohan Agarwal; Sumit Sharma

What’s known on the subject? and What does the study add?


Neurourology and Urodynamics | 2009

Re: Uroflowmetry in healthy women: Development and validation of flow—volume and corrected flow—age nomograms

Mayank Mohan Agarwal

Voiding dysfunction is common among women. However, unlike men, no universally accepted nomogram is available for them. This study was undertaken to establish normal reference values of urinary flow parameters for healthy Indian female population in menstrual age group.


International Journal of Urology | 2006

Primary renal inflammatory malignant fibrous histiocytoma : A diagnostic challenge

Shrawan Kumar Singh; Arup K. Mandal; Mayank Mohan Agarwal; Ashim Das

Abstract  Renal inflammatory malignant fibrous histiocytoma (MFH) is an extremely rare lesion and is a great masquerader of common benign renal inflammatory lesions, especially xanthogranulomatous pyelonephritis (XGPN). The clinical presentation of mass with fever and peripheral leucocytosis (marked at times), and marked inflammatory, predominantly neutrophilic, infiltrate obscuring the malignant cells on histopathology, can lead to delay in the diagnosis of this poor prognostic malignant tumor. We present the case of a patient who underwent radical nephrectomy with a clinical diagnosis of renal malignancy, but histopathology showing XGPN. The patient showed an initial clinical response, only to recur two times, ultimately leading to a histological and immunohistochemical diagnosis of inflammatory MFH. The diagnosis, histology, therapeutic options and prognosis of this rare lesion are discussed.


Urology | 2010

Surgicel Granuloma: Unusual Cause of “Recurrent” Mass Lesion After Laparoscopic Nephron-sparing Surgery for Renal Cell Carcinoma

Mayank Mohan Agarwal; Arup K. Mandal; Santosh Agarwal; Anupam Lal; Mahesh Prakash; Ravimohan Mavuduru; Shrawan Kumar Singh

We present the first clinical report of Surgicel granuloma after laparoscopic nephron-sparing surgery and present the characteristics of this radiological image mimicking local recurrence. A 47-year-old man underwent laparoscopic nephron-sparing surgery for left renal interpolar incidentaloma; Surgicel bolsters were used for hemostasis. Histological examination revealed conventional clear-cell renal cell carcinoma with negative surgical margins. Magnetic resonance imaging at 3 months revealed a 2.5-cm enhancing mass in the region of nephron-sparing surgery. Computed tomography-guided core biopsy revealed foreign-body granuloma. Serial magnetic resonance imaging showed a decrease in the size/enhancement of the lesion during 12 months. To conclude, Surgicel may invoke foreign-body reaction leading to formation of pseudotumor, which leads to diagnostic dilemma.

Collaboration


Dive into the Mayank Mohan Agarwal's collaboration.

Top Co-Authors

Avatar

Arup K. Mandal

Post Graduate Institute of Medical Education and Research

View shared research outputs
Top Co-Authors

Avatar

Shrawan Kumar Singh

Post Graduate Institute of Medical Education and Research

View shared research outputs
Top Co-Authors

Avatar

Ravimohan Mavuduru

Post Graduate Institute of Medical Education and Research

View shared research outputs
Top Co-Authors

Avatar

Santosh Kumar

Mahatma Gandhi Institute of Medical Sciences

View shared research outputs
Top Co-Authors

Avatar

Naveen Acharya

Post Graduate Institute of Medical Education and Research

View shared research outputs
Top Co-Authors

Avatar

Uttam Mete

Post Graduate Institute of Medical Education and Research

View shared research outputs
Top Co-Authors

Avatar

Madhu S. Agrawal

All India Institute of Medical Sciences

View shared research outputs
Top Co-Authors

Avatar

Niranjan Khandelwal

Post Graduate Institute of Medical Education and Research

View shared research outputs
Top Co-Authors

Avatar

Anupam Lal

Post Graduate Institute of Medical Education and Research

View shared research outputs
Top Co-Authors

Avatar

Debansu Sarkar

Post Graduate Institute of Medical Education and Research

View shared research outputs
Researchain Logo
Decentralizing Knowledge